MedTrace Logo

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

NCT04146337 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-11-29

No results posted yet for this study

Summary

2:1, open-label, single center, randomized controlled trial comparing FMT vs. no intervention for CRE carriers,

Conditions

  • Carbapenem-Resistant Enterobacteriaceae Infection

Interventions

BIOLOGICAL

FMT

Fecal microbiota in frozen capsules

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Haggay Bar Yoseph, MD · Rambam Health Care Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146337 on ClinicalTrials.gov